Skip to content

Effects of propofol and sevoflurane anesthesia on cerebrospinal fluid proteomics:a randomized controlled trial

Effects of propofol and sevoflurane anesthesia on cerebrospinal fluid proteomics:a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020742
Enrollment
Unknown
Registered
2019-01-16
Start date
2019-01-15
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Sponsors

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II grade; 2. Age 18-65 years old; 3. Continuous spinal anesthesia for lower limb surgery; 4. Surgical time greater than 3 hours; 5. Voluntary participation in the trial and signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Heart disease (placement pacemaker, frequent arrhythmia, atrial fibrillation, etc.); 2. Lung disease (pulmonary infection, emphysema, chronic obstructive pulmonary disease, etc.); 3. Renal function damage (BUN and / or Cr > upper limit of normal); 4. Liver function damage (ALT and / or AST > 1.5 times normal value reference range); 5. Patients with coagulopathy (PT / APTT higher than the reference limit); 6. Recent or long-term use Anticoagulation or anti-platelet aggregation drugs; 7. Preoperative hemoglobin concentration, hematocrit (Hct) is not in the normal range; 8. History of hypertension and blood pressure systolic blood pressure > 180 or diastolic blood pressure > 110mmHg two consecutive measurements did not decline; 9. Patients suffering from mental, neurological diseases, or unable to correctly express willingness; 10. Long-term use of patients with sedative analgesia, psychotropic drugs; 11. Patients with chronic alcoholism or drug abuse; 12. Spinal trauma or severe low back pain; 13. Neuromuscular disease (specifically, paraplegia, myasthenia gravis); 14. Patients with severe systemic infection or infection of the lower back; 15. Patients who refused to undergo spinal canal puncture; 16. Known difficult airways; 17. Allergic to the drugs used in this subject.

Design outcomes

Primary

MeasureTime frame
Proteomics;

Secondary

MeasureTime frame
blood pressure;Heart rate;Pulse oximetry;Bispectral index;

Countries

China

Contacts

Public ContactHan Lin

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

nanlinhannansh@qq.com+86 1586871083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026